Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 465

1.

Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.

Acs G, Dumoff KL, Solin LJ, Pasha T, Xu X, Zhang PJ.

Am J Surg Pathol. 2007 Jan;31(1):129-40.

PMID:
17197929
2.

The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma.

Acs G, Paragh G, Rakosy Z, Laronga C, Zhang PJ.

Mod Pathol. 2012 Feb;25(2):163-77. doi: 10.1038/modpathol.2011.138. Epub 2011 Oct 21.

3.

The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma.

Acs G, Paragh G, Chuang ST, Laronga C, Zhang PJ.

Am J Surg Pathol. 2009 Feb;33(2):202-10. doi: 10.1097/PAS.0b013e318185e171.

PMID:
18987549
4.

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.

Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN.

Mod Pathol. 2007 Feb;20(2):183-91. Epub 2007 Jan 5.

5.

Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.

Acs G, Esposito NN, Rakosy Z, Laronga C, Zhang PJ.

Am J Surg Pathol. 2010 Nov;34(11):1637-46. doi: 10.1097/PAS.0b013e3181f5539c.

PMID:
20975342
6.
7.

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.

Breast Cancer Res Treat. 2007 Mar;101(3):279-84. Epub 2006 Jul 12.

PMID:
16835704
8.
9.
10.

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.

Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.

Hum Pathol. 2008 Dec;39(12):1809-15. doi: 10.1016/j.humpath.2008.05.010. Epub 2008 Aug 19.

PMID:
18715613
11.

Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.

Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, Hughes KS.

Cancer. 1996 Feb 1;77(3):490-8.

12.
13.

FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.

14.

Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.

Belev B, Alerić I, Vrbanec D, Petrovecki M, Unusic J, Jakić-Razumović J.

Acta Oncol. 2002;41(4):355-61.

PMID:
12234027
15.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
17.

Pathologic correlates of prognosis in lymph node-positive breast carcinomas.

Clayton F, Hopkins CL.

Cancer. 1993 Mar 1;71(5):1780-90.

18.

Correlated expression of erbB-3 with hormone receptor expression and favorable clinical outcome in invasive ductal carcinomas of the breast.

Lee Y, Cho S, Seo JH, Shin BK, Kim HK, Kim I, Kim A.

Am J Clin Pathol. 2007 Dec;128(6):1041-9.

PMID:
18024331
19.

[Clinical characteristics and prognosis of breast cancer patients with vascular invasion].

Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):137-40. Chinese.

PMID:
17645853
20.

Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior.

Jimenez RE, Wallis T, Visscher DW.

Am J Surg Pathol. 2001 Mar;25(3):331-7.

PMID:
11224603

Supplemental Content

Support Center